// App-Quantinova.ai

252 : Patient stem cell (SC)-derived prostate cancer (PC) organoids (Org) to recreate clonal heterogeneity of PC foci and measure therapeutic response potential.

Researchers

Presenter

  • Anna C. Ferrari

Principal Investigators

  • Robert S. DiPaola

  • Joseph R. Bertino

  • Isaac Yi Kim

  • Mark N. Stein

  • Hatem E. Sabaawy

  • Monica Bartucci

Medical Centers

  • New York University, New York, NY

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • Rutgers Cancer Institute of New Jersey, Branford, CT

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Polycomb complex protein

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved